Robert L. Findling
Director
PsychiatryÂ
Kennedy Krieger Institute
United States of America
Biography
BIOGRAPHICAL SKETCH: Dr. Findling did his undergraduate work at Johns Hopkins University and went to medical school at the Medical College of Virginia. Dr. Findling then completed training in Pediatrics, Psychiatry, and Child & Adolescent Psychiatry as part of the “Triple Board” joint training program at Mt. Sinai in New York. He subsequently earned his Masters of Business Administration degree at a joint program run by the London School of Economics, NYU Stern, and HEC Paris called “Trium”. After serving as the Rocco L. Motto, M.D. Chair of Child and Adolescent Psychiatry at Case Western Reserve University School of Medicine and Director of the Division of Child and Adolescent Psychiatry at University Hospitals Case Medical Center, Dr. Findling returned to Baltimore in 2012. RESEARCH SUMMARY: Dr. Findling has achieved international recognition as a clinician and an educator. His investigative endeavors have focused on pediatric psychopharmacology and serious psychiatric disorders in the young. Dr. Findling has authored over 300 scientific articles as well as several books. His research is supported by the National Institutes of Health, the Stanley Medical Research Institute, and the pharmaceutical industry. RESEARCH STUDIES: Dr. Findling serves as both a principal investigator and co-investigator on numerous research protocols in both typically-developing and atypically-developing children that are being conducted under the auspices of Kennedy Krieger’s Clinical Trials Unit.
Research Interest
Psychiatry
Publications
-
"1. Findling RL, Landbloom RL, Mackle M, Wu X, Snow-Adami L, Chang K, Durgam S. Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial. Paediatr Drugs (2016). 2. Findling RL, Groark J, Tourian KA, Ramaker SA, Chiles D, Yang L, Nichols AI. Pharmacokinetics and Tolerability of Single-Ascending Doses of Desvenlafaxine Administered to Children and Adolescents with Major Depressive Disorder. J Child Adolesc Psychopharmacol (2016). 3. Ong ML, Youngstrom EA, Chua JJ, Halverson TF, Horwitz SM, Storfer-Isser A, Frazier TW, Fristad MA, Arnold LE, Phillips ML, Birmaher B, Kowatch RA, Findling RL, LAMS Group. Comparing the CASI-4R and the PGBI-10 M for Differentiating Bipolar Spectrum Disorders from Other Outpatient Diagnoses in Youth. J Abnorm Child Psychol (2016). 4. Landersdorfer CB, Findling RL, Frazier JA, Kafantaris V, Kirkpatrick CM. Lithium in Paediatric Patients with Bipolar Disorder: Implications for Selection of Dosage Regimens via Population Pharmacokinetics/Pharmacodynamics. Clin Pharmacokinet (2016). 5. Van Meter AR, Burke C, Kowatch RA, Findling RL, Youngstrom EA. Ten-year updated meta-analysis of the clinical characteristics of pediatric mania and hypomania. Bipolar Disord (2016) 18: 19-32.
